tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Richard Newitter, 472 are a BUY (63.61%), 270 are a HOLD (36.39%).
Analyst Richard Newitter, currently employed at TRUIST, carries an average stock price target met ratio of 65.31% that have a potential upside of 27.33% achieved within 256 days.
Richard Newitter’s has documented 1,474 price targets and ratings displayed on 45 stocks. The coverage is on Healthcare, Financial Services, Technology, Communication Services sectors.
Most recent stock forecast was given on BSX, Boston Scientific Corp at 14-Oct-2026.
Analyst best performing recommendations are on TNDM (TANDEM DIABETES CARE).
The best stock recommendation documented was for INSP (INSPIRE MEDICAL SYSTEMS) at 11/24/2025. The price target of $128 was fulfilled within 1 day with a profit of $10.71 (9.13%) receiving and performance score of 91.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Oct-2022
$74
$7.82 (11.82%)
$82
8 days ago
(12-Oct-2026)
12/24 (50%)
$9.89 (15.43%)
108
Hold Since 13-Oct-2025
$70
$3.82 (5.77%)
$78
13 days ago
(07-Oct-2026)
12/15 (80%)
$7 (11.11%)
575
Buy Since 08-Apr-2022
$98
$31.82 (48.08%)
$98
1 months 5 days ago
(15-Sep-2026)
14/32 (43.75%)
$30.24 (44.63%)
418
Hold Since 12-Aug-2026
$78.4
$12.22 (18.46%)
$77.53
2 months 8 days ago
(12-Aug-2026)
3/4 (75%)
$4.82 (6.55%)
99
Buy Since 15-Apr-2019
$85
$18.82 (28.44%)
$80
2 months 8 days ago
(12-Aug-2026)
10/21 (47.62%)
$11.42 (15.52%)
389
Which stock is Richard Newitter most bullish on?
Which stock is Richard Newitter most reserved on?
What Year was the first public recommendation made by Richard Newitter?
